Oligonucleotides targeting prion diseases

Details for Australian Patent Application No. 2004271807 (hide)

Owner Replicor, Inc.

Inventors Juteau, Jean-Marc; Juteau, Jean-Marc; Vaillant, Andrew; Vaillant, Andrew

Agent FB Rice

Pub. Number AU-A-2004271807

PCT Pub. Number WO2005/025487

Priority PCT/IB03/04573 11.09.03 IB; 60/584,627 06.06.04 US

Filing date 10 September 2004

Wipo publication date 24 March 2005

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/025487 Priority application(s): WO2005/025487

8 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004271817-Automatic injection device

2004271805-Treatment of gastroparesis and nonulcer dyspepsia with GABAb agonists